Proposed herein is the development of new chemistry for the de novo synthesis of carbohydrates and the use of this new methodology for the synthesis of new bioactive molecules. These new bioactive structures may have activities against a range of diseases. This proposal is focus on anticancer and antibacterial compounds. The approach toward cancer is to use this new methodology to preform novel SAR studies on the carbohydrate portion of known natural products with anticancer activity. This approach will be conducted on the carbohydrate portions of digitoxin, SL0101 and Landomycin A. With regard to antibacterial agents this proposal is focused on addressing the problem of bacterial resistance. The major objectives of this proposal are to develop a concise methodology toward unnatural sugars, to develop a method for the assembly of unnatural sugars into unnatural oligosaccharides and to incorporate these unnatural sugars into carbohydrate based antibiotics, etc. Having unnatural sugar analogues of these antibiotics/antitumor agents would greatly aid in revealing which functional groups are important to these molecular interactions and in turn help prepared new more potent drugs.

Public Health Relevance

This project from the department of chemistry at West Virginia University proposes to develop a new technology (glycosylation/cyclitolization) for the installation of natural and unnatural complex carbohydrates into existing natural product structural motifs. These new carbohydrate structures are based on naturally occurring structural motifs that nature use to impart biological activity into its existing natural products. Ultimately, we plan to uses these new compounds to development new pharmaceutical based therapies for the treatment of cancer and various infectious diseases. In addition, it is believed that this new approach will empower medicinal chemist to carry out new SAR type studies on the carbohydrate subunits of natural products.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM088839-02
Application #
7914474
Study Section
Synthetic and Biological Chemistry A Study Section (SBCA)
Program Officer
Hagan, Ann A
Project Start
2009-08-15
Project End
2010-08-31
Budget Start
2010-08-01
Budget End
2010-08-31
Support Year
2
Fiscal Year
2010
Total Cost
$3,254
Indirect Cost
Name
West Virginia University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
191510239
City
Morgantown
State
WV
Country
United States
Zip Code
26506
Ludwik, Katarzyna A; Campbell, J Preston; Li, Mingzong et al. (2016) Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer. Mol Cancer Ther 15:2598-2608
Bajaj, Sumit O; Sharif, Ehesan U; Akhmedov, Novruz G et al. (2014) De novo asymmetric synthesis of the mezzettiaside family of natural products via the iterative use of a dual B-/Pd-catalyzed glycosylation. Chem Sci 5:2230-2234
Sharif, Ehesan U; Wang, Hua-Yu Leo; Akhmedov, Novruz G et al. (2014) Merremoside D: de novo synthesis of the purported structure, NMR analysis, and comparison of spectral data. Org Lett 16:492-5
Mrozowski, Roman M; Sandusky, Zachary M; Vemula, Rajender et al. (2014) De novo synthesis and biological evaluation of C6?-substituted C4?-amide analogues of SL0101. Org Lett 16:5996-9
Pongrakhananon, Varisa; Stueckle, Todd A; Wang, Hua-Yu Leo et al. (2014) Monosaccharide digitoxin derivative sensitize human non-small cell lung cancer cells to anoikis through Mcl-1 proteasomal degradation. Biochem Pharmacol 88:23-35
Elbaz, Hosam A; Stueckle, Todd A; Wang, Hua-Yu Leo et al. (2012) Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells. Toxicol Appl Pharmacol 258:51-60
Mrozowski, Roman M; Vemula, Rajender; Wu, Bulan et al. (2012) Improving the affinity of SL0101 for RSK using structure-based design. ACS Med Chem Lett 4:175-179
Sharif, Ehesan U; O'Doherty, George A (2012) Biosynthesis and Total Synthesis Studies on The Jadomycin Family of Natural Products. European J Org Chem 2012:
Wang, Hua-Yu Leo; Xin, Wenjun; Zhou, Maoquan et al. (2011) Stereochemical survey of digitoxin monosaccharides: new anticancer analogues with enhanced apoptotic activity and growth inhibitory effect on human non-small cell lung cancer cell. ACS Med Chem Lett 2:73-78
Yu, Xiaomei; Li, Miaosheng; O'Doherty, George A (2011) DE NOVO ASYMMETRIC APPROACH TO THE DISACCHARIDE PORTION OF SCH-47554. Heterocycles 82:1577-1584

Showing the most recent 10 out of 19 publications